Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale - Second Edition
- PMID: 40188616
- PMCID: PMC12082261
- DOI: 10.1016/j.psychres.2025.116456
Psychometric properties of the Spanish Yale-Brown Obsessive-Compulsive Scale - Second Edition
Abstract
The Yale-Brown Obsessive-Compulsive Scale, Second Edition (Y-BOCS-II) is an evidence-based clinician-rated measure for assessing the presence and severity of obsessive-compulsive symptoms. The Spanish version of the Y-BOCS-II has not yet been validated. The present study examines the psychometric properties of the Spanish Y-BOCS-II (Spanish-Y-BOCS-II) in adults with obsessive-compulsive disorder (OCD) who are of Hispanic/Latino ancestry. The Spanish-Y-BOCS-II was administered to 1805 adults with OCD. Participants also completed a battery of measures assessing OCD, depression, and anxiety symptoms. The internal consistency for the Symptom Checklist (Kuder-Richardson-20=0.92), Obsession Severity (α=0.87), Compulsion Severity (α=0.86), and Total Severity (α=0.92) were high. The inter-rater reliability for the Severity Scale (intraclass correlations=0.98) was excellent. Confirmatory factor analyses showed a marginally acceptable fit with the Obsessions and Compulsions two-factor model; subsequent exploratory factor analysis revealed a one-factor solution consistent with a Total score including all items. Satisfactory construct validity was observed, supported by the strong correlations with other measures of obsessive-compulsive symptom severity and moderate correlations with measures of depression and anxiety symptoms. Overall, the Spanish-Y-BOCS-II demonstrates acceptable reliability and validity properties.
Keywords: Assessment; Hispanic; Latino; Obsessive-compulsive disorder; Reliability; Spanish; Validity; Yale-brown obsessive-compulsive scale, second edition.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr. Storch reports receiving research funding to his institution from the Ream Foundation, International OCD Foundation, and NIH. He is a consultant for Brainsway and Biohaven Pharmaceuticals. He owns stock less than $5000 in NView. He receives book royalties from Elsevier, Wiley, Oxford, American Psychological Association, Guildford, Springer, Routledge, and Jessica Kingsley. Dr. Goodman receives research fundings from NIH, Biohaven, and the McNair Foundation and consulting fees from Biohaven. He receives royalties from Proem. Dr. Rodriguez (in the last three years) has been a consultant for Biohaven Inc., Osmind, and Biogen; received research grant support from Biohaven Inc.; received royalties from American Psychiatric Association Publishing; and received a stipend from APA Publishing for her role as Deputy Editor at The American Journal of Psychiatry and a stipend for her role as Deputy Editor of Neuropsychopharmacology. Dr. Arnold receives research funding from Biohaven, Canadian Institute for Health Research, Ontario Brain Institute, and Alberta Children's Hospital Research Foundation Dr. Martínez-González receives funding from NIH and FDA. She is a consultant with Abbvie, Sage Pharmaceuticals and SAMHSA. All other authors report no financial disclosures.
References
-
- Alić M, de Leeuw A, Selier J, van Megen H, & Visser H (2022). Responsiveness and other psychometric properties of the Yale-Brown Obsessive-Compulsive Scale Severity Scale-Second Edition in a Dutch clinical sample. Clinical Psychology & Psychotherapy, 29(4), 1355–1363. 10.1002/cpp.2715 - DOI - PubMed
-
- Amir N, Foa EB, & Coles ME (1997). Factor structure of the Yale–Brown Obsessive Compulsive Scale. Psychological Assessment, 9(3), 312.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
